Breakthrough Research. New Perspectives. Actionable Insights.
Designed for business and science leaders like you
From functional genomics and drug discovery, to health care policy and benefits, oncology and the microbiome, HMS’s executive-level open enrollment programs deliver new insights that position business and science leaders to unlock opportunities in a dynamic and rapidly changing health care landscape.
Programs are taught by HMS faculty, faculty from other Schools at Harvard University and industry-leading practitioners.
Program Offerings
-
Innovations in Digital Health: Technologies Shaping the Future of Health Care
Led by John D. Halamka, MD, MSMarch 12-14, 2019“Innovations in Digital Health” is a 2.5-day executive education program that will help industry leaders, investors and policy makers understand these nuances so that they can set a digital health strategy for their organizations. Led by Dr. John Halamka, a practicing physician and digital health visionary, this program will provide participants with firsthand perspectives from the front lines of health care and digital health.
Learn more on our program page here.
-
The Microbiome: Emerging Opportunities for Biopharma
Led by Ramnik Xavier, MD, PhDApril 18-19, 2019Excitement and investment in the microbiome and its near-term opportunities for the biopharma industry are rapidly increasing. As the microbiome is implicated in progressively more diseases, emerging studies have validated the concept of microbiome-based diagnostics and therapeutics.
Led by Ramnik Xavier, MD, PhD, participants will come away with a framework to guide their thinking about how to evaluate microbiome programs, identify emerging areas of opportunity and set strategic priorities for research , discovery and investment.
Learn more about our program here
-
Inside the Health Care Ecosystem: Strategic Insights for Business Leaders
Led by Stanley Y. Shaw, MD, PhDMay 20-24, 2019“Inside the Health Care Ecosystem: Strategic Insights for Business Leaders” is a new program that provides business and science leaders with insights into the science and practice of medicine. Through it, participants will be exposed to real-world workflows and health care delivery in action, as well as the firsthand perspectives of patients and providers.
Learn more on our program page here.
-
Functional Genomics & Drug Discovery: New Approaches for Decision Making
Led by Sekar Kathiresan, MDJune 4-5, 2019This program is a unique opportunity to delve into the use of genomics in rare and complex diseases, and throughout the drug discovery, development, regulatory and post-regulatory phases.
Learn more on our program page here.